{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:05:42Z","timestamp":1783699542766,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00381-016-3257-1","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T16:46:16Z","timestamp":1475599576000},"page":"2403-2413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation"],"prefix":"10.1007","volume":"32","author":[{"given":"Nicolas -Xavier","family":"Bonne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Aboukais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Baroncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Hochart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Broly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Dubrulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"3257_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-4-16","volume":"4","author":"DGR Evans","year":"2009","unstructured":"Evans DGR (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 4:16. doi: 10.1186\/1750-1172-4-16","journal-title":"Orphanet J Rare Dis"},{"key":"3257_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","volume":"49","author":"A Wilding","year":"2012","unstructured":"Wilding A, Ingham SL, Lalloo F, et al. (2012) Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 49:264\u2013269. doi: 10.1136\/jmedgenet-2011-100562","journal-title":"J Med Genet"},{"key":"3257_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3171\/jns.2003.99.3.0480","volume":"99","author":"G Otsuka","year":"2003","unstructured":"Otsuka G, Saito K, Nagatani T, Yoshida J (2003) Age at symptom onset and long-term survival in patients with neurofibromatosis type 2. J Neurosurg 99:480\u2013483. doi: 10.3171\/jns.2003.99.3.0480","journal-title":"J Neurosurg"},{"key":"3257_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/adc.81.6.496","volume":"81","author":"DG Evans","year":"1999","unstructured":"Evans DG, Birch JM, Ramsden RT (1999) Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 81:496\u2013499","journal-title":"Arch Dis Child"},{"key":"3257_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/00006123-198201000-00001","volume":"10","author":"RL Martuza","year":"1982","unstructured":"Martuza RL, Ojemann RG (1982) Bilateral acoustic neuromas: clinical aspects, pathogenesis, and treatment. Neurosurgery 10:1\u201312","journal-title":"Neurosurgery"},{"key":"3257_CR6","first-page":"323","volume":"46","author":"GA Rouleau","year":"1990","unstructured":"Rouleau GA, Seizinger BR, Wertelecki W, et al. (1990) Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet 46:323\u2013328","journal-title":"Am J Hum Genet"},{"key":"3257_CR7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0092-8674(93)90501-G","volume":"75","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL, et al. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75:826","journal-title":"Cell"},{"key":"3257_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, et al. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515\u2013521. doi: 10.1038\/363515a0","journal-title":"Nature"},{"key":"3257_CR9","first-page":"77","volume":"77","author":"AG Knudson","year":"1974","unstructured":"Knudson AG (1974) Heredity and human cancer. Am J Pathol 77:77\u201384","journal-title":"Am J Pathol"},{"key":"3257_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1203\/00006450-197605000-00001","volume":"10","author":"AG Knudson","year":"1976","unstructured":"Knudson AG (1976) Genetics and the etiology of childhood cancer. Pediatr Res 10:513\u2013517. doi: 10.1203\/00006450-197605000-00001","journal-title":"Pediatr Res"},{"key":"3257_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.wco.0000053583.70044.ab","volume":"16","author":"ME Baser","year":"2003","unstructured":"Baser ME, Evans DGR, Gutmann DH (2003) Neurofibromatosis 2. Curr Opin Neurol 16:27\u201333. doi: 10.1097\/01.wco.0000053583.70044.ab","journal-title":"Curr Opin Neurol"},{"key":"3257_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jmg.2006.047753","volume":"44","author":"DGR Evans","year":"2007","unstructured":"Evans DGR, Ramsden RT, Shenton A, et al. (2007) Mosaicism in neurofibromatosis type 2: an update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet 44:424\u2013428. doi: 10.1136\/jmg.2006.047753","journal-title":"J Med Genet"},{"key":"3257_CR13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.47.5.1269","volume":"47","author":"ME Baser","year":"1996","unstructured":"Baser ME, Mautner VF, Ragge NK, et al. (1996) Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations. Neurology 47:1269\u20131277","journal-title":"Neurology"},{"key":"3257_CR14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/jmg.37.12.944","volume":"37","author":"DG Evans","year":"2000","unstructured":"Evans DG, Newton V, Neary W, et al. (2000) Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2. J Med Genet 37:944\u2013947","journal-title":"J Med Genet"},{"key":"3257_CR15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archotol.1995.01890050078016","volume":"121","author":"GR Harsh","year":"1995","unstructured":"Harsh GR, MacCollin M, McKenna MJ, et al. (1995) Molecular genetic screening for children at risk of neurofibromatosis 2. Arch Otolaryngol Head Neck Surg 121:590\u2013591","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"3257_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/humu.20679","volume":"29","author":"R Sestini","year":"2008","unstructured":"Sestini R, Bacci C, Provenzano A, et al. (2008) Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 29:227\u2013231. doi: 10.1002\/humu.20679","journal-title":"Hum Mutat"},{"key":"3257_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng.2855","volume":"46","author":"A Piotrowski","year":"2014","unstructured":"Piotrowski A, Xie J, Liu YF, et al. (2014) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46:182\u2013187. doi: 10.1038\/ng.2855","journal-title":"Nat Genet"},{"key":"3257_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajmg.1320520411","volume":"52","author":"DM Parry","year":"1994","unstructured":"Parry DM, Eldridge R, Kaiser-Kupfer MI, et al. (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450\u2013461. doi: 10.1002\/ajmg.1320520411","journal-title":"Am J Med Genet"},{"key":"3257_CR19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1227\/00006123-199307000-00014","volume":"33","author":"VF Mautner","year":"1993","unstructured":"Mautner VF, Tatagiba M, Guthoff R, et al. (1993) Neurofibromatosis 2 in the pediatric age group. Neurosurgery 33:92\u201396","journal-title":"Neurosurgery"},{"key":"3257_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2005-837581","volume":"36","author":"M Ruggieri","year":"2005","unstructured":"Ruggieri M, Iannetti P, Polizzi A, et al. (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36:21\u201334. doi: 10.1055\/s-2005-837581","journal-title":"Neuropediatrics"},{"key":"3257_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10048-013-0354-0","volume":"14","author":"M Ruggieri","year":"2013","unstructured":"Ruggieri M, Gabriele AL, Polizzi A, et al. (2013) Natural history of neurofibromatosis type 2 with onset before the age of 1\u00a0year. Neurogenetics 14:89\u201398. doi: 10.1007\/s10048-013-0354-0","journal-title":"Neurogenetics"},{"key":"3257_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3171\/ped.2007.106.4.255","volume":"106","author":"WH Slattery 3rd","year":"2007","unstructured":"Slattery WH 3rd, Fisher LM, Hitselberger W, et al. (2007) Hearing preservation surgery for neurofibromatosis type 2-related vestibular schwannoma in pediatric patients. J Neurosurg 106:255\u2013260. doi: 10.3171\/ped.2007.106.4.255","journal-title":"J Neurosurg"},{"key":"3257_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/archotol.130.5.656","volume":"130","author":"SR Otto","year":"2004","unstructured":"Otto SR, Brackmann DE, Hitselberger W (2004) Auditory brainstem implantation in 12- to 18-year-olds. Arch Otolaryngol Head Neck Surg 130:656\u2013659. doi: 10.1001\/archotol.130.5.656","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"3257_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00129492-200503000-00017","volume":"26","author":"CD Cunningham","year":"2005","unstructured":"Cunningham CD, Friedman RA, Brackmann DE, et al. (2005) Neurotologic skull base surgery in pediatric patients. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 26:231\u2013236","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/02688690902968844","volume":"23","author":"SP MacNally","year":"2009","unstructured":"MacNally SP, Rutherford SA, King AT, et al. (2009) Outcome from surgery for vestibular schwannomas in children. Br J Neurosurg 23:226\u2013231. doi: 10.1080\/02688690902968844","journal-title":"Br J Neurosurg"},{"key":"3257_CR26","first-page":"259","volume":"119","author":"K Niemczyk","year":"2002","unstructured":"Niemczyk K, Dubrulle F, Vaneecloo FM, et al. (2002) Clinical implications of acoustic neuromas growth rate in volumetric study. Ann Oto-Laryngol Chir Cervico Faciale Bull Soci\u00e9t\u00e9 Oto-Laryngol H\u00f4pitaux Paris 119:259\u2013263","journal-title":"Ann Oto-Laryngol Chir Cervico Faciale Bull Soci\u00e9t\u00e9 Oto-Laryngol H\u00f4pitaux Paris"},{"key":"3257_CR27","first-page":"244","volume":"20","author":"K Niemczyk","year":"1999","unstructured":"Niemczyk K, Vaneecloo FM, Lemaitre L, et al. (1999) The growth of acoustic neuromas in volumetric radiologic assessment. Am J Otol 20:244\u2013248","journal-title":"Am J Otol"},{"key":"3257_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1148\/radiology.215.2.r00ma20458","volume":"215","author":"F Dubrulle","year":"2000","unstructured":"Dubrulle F, Ernst O, Vincent C, et al. (2000) Cochlear fossa enhancement at MR evaluation of vestibular schwannoma: correlation with success at hearing-preservation surgery. Radiology 215:458\u2013462. doi: 10.1148\/radiology.215.2.r00ma20458","journal-title":"Radiology"},{"key":"3257_CR29","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1097\/MAO.0b013e3182355855","volume":"32","author":"RA Friedman","year":"2011","unstructured":"Friedman RA, Goddard JC, Wilkinson EP, et al. (2011) Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 32:1530\u20131537. doi: 10.1097\/MAO.0b013e3182355855","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR30","first-page":"274","volume":"49","author":"DE Brackmann","year":"2001","unstructured":"Brackmann DE, Fayad JN, Slattery WH 3rd, et al. (2001) Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 49:274\u2013280 discussion 280\u2013283","journal-title":"Neurosurgery"},{"key":"3257_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/MAO.0b013e3181e8fc3f","volume":"31","author":"JC Goddard","year":"2010","unstructured":"Goddard JC, Schwartz MS, Friedman RA (2010) Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 31:1128\u20131134. doi: 10.1097\/MAO.0b013e3181e8fc3f","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR32","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/MAO.0b013e318254ede3","volume":"33","author":"C Vincent","year":"2012","unstructured":"Vincent C, Bonne N-X, Gu\u00e9rin C, et al. (2012) Middle fossa approach for resection of vestibular schwannoma: impact of cochlear fossa extension and auditory monitoring on hearing preservation. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 33:849\u2013852. doi: 10.1097\/MAO.0b013e318254ede3","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/MAO.0b013e3182267eb7","volume":"32","author":"WH Slattery","year":"2011","unstructured":"Slattery WH, Hoa M, Bonne N, et al. (2011) Middle fossa decompression for hearing preservation: a review of institutional results and indications. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 32:1017\u20131024. doi: 10.1097\/MAO.0b013e3182267eb7","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/MAO.0b013e3181f7ab47","volume":"31","author":"S Tringali","year":"2010","unstructured":"Tringali S, Ferber-Viart C, Fuchsmann C, et al. (2010) Hearing preservation in retrosigmoid approach of small vestibular schwannomas: prognostic value of the degree of internal auditory canal filling. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 31:1469\u20131472","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/02688699550041412","volume":"9","author":"M Samii","year":"1995","unstructured":"Samii M (1995) Hearing preservation in bilateral acoustic neurinomas. Br J Neurosurg 9:413\u2013424","journal-title":"Br J Neurosurg"},{"key":"3257_CR36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006123-199704000-00007","volume":"40","author":"M Samii","year":"1997","unstructured":"Samii M, Matthies C, Tatagiba M (1997) Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 40:696\u2013705 discussion 705\u2013706","journal-title":"Neurosurgery"},{"key":"3257_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3171\/jns.1994.80.3.0541","volume":"80","author":"J J\u00e4\u00e4skel\u00e4inen","year":"1994","unstructured":"J\u00e4\u00e4skel\u00e4inen J, Paetau A, Pyykk\u00f6 I, et al. (1994) Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases. J Neurosurg 80:541\u2013547. doi: 10.3171\/jns.1994.80.3.0541","journal-title":"J Neurosurg"},{"key":"3257_CR38","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/lary.21822","volume":"121","author":"S-I Nam","year":"2011","unstructured":"Nam S-I, Linthicum FH, Merchant SN (2011) Temporal bone histopathology in neurofibromatosis type 2. Laryngoscope 121:1548\u20131554. doi: 10.1002\/lary.21822","journal-title":"Laryngoscope"},{"key":"3257_CR39","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1288\/00005537-199211000-00003","volume":"102","author":"RA Cueva","year":"1992","unstructured":"Cueva RA, Thedinger BA, Harris JP, Glasscock ME (1992) Electrical promontory stimulation in patients with intact cochlear nerve and anacusis following acoustic neuroma surgery. Laryngoscope 102:1220\u20131224. doi: 10.1288\/00005537-199211000-00003","journal-title":"Laryngoscope"},{"key":"3257_CR40","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/00016480802510202","volume":"129","author":"P Tran Ba Huy","year":"2009","unstructured":"Tran Ba Huy P, Kania R, Frachet B, et al. (2009) Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2. Acta Otolaryngol (Stockh) 129:971\u2013975. doi: 10.1080\/00016480802510202","journal-title":"Acta Otolaryngol (Stockh)"},{"key":"3257_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000115437","volume":"13","author":"V Vincenti","year":"2008","unstructured":"Vincenti V, Pasanisi E, Guida M, et al. (2008) Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation. Audiol Neurootol 13:273\u2013280. doi: 10.1159\/000115437","journal-title":"Audiol Neurootol"},{"key":"3257_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/MLG.0b013e31804b1ae7","volume":"117","author":"BA Neff","year":"2007","unstructured":"Neff BA, Wiet RM, Lasak JM, et al. (2007) Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 117:1069\u20131072. doi: 10.1097\/MLG.0b013e31804b1ae7","journal-title":"Laryngoscope"},{"key":"3257_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MAO.0b013e3181c348e7","volume":"31","author":"MI Trotter","year":"2010","unstructured":"Trotter MI, Briggs RJS (2010) Cochlear implantation in neurofibromatosis type 2 after radiation therapy. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 31:216\u2013219. doi: 10.1097\/MAO.0b013e3181c348e7","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR44","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3171\/2011.5.JNS101929","volume":"115","author":"PC Roehm","year":"2011","unstructured":"Roehm PC, Mallen-St Clair J, Jethanamest D, et al. (2011) Auditory rehabilitation of patients with neurofibromatosis type 2 by using cochlear implants. J Neurosurg 115:827\u2013834. doi: 10.3171\/2011.5.JNS101929","journal-title":"J Neurosurg"},{"key":"3257_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/01.mao.0000217351.86925.51","volume":"27","author":"LR Lustig","year":"2006","unstructured":"Lustig LR, Yeagle J, Driscoll CLW, et al. (2006) Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 27:512\u2013518. doi: 10.1097\/01.mao.0000217351.86925.51","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00129492-200201000-00014","volume":"23","author":"C Vincent","year":"2002","unstructured":"Vincent C, Zini C, Gandolfi A, et al. (2002) Results of the MXM Digisonic auditory brainstem implant clinical trials in Europe. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 23:56\u201360","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/MAO.0b013e3181db7055","volume":"31","author":"V Colletti","year":"2010","unstructured":"Colletti V, Shannon RV, Carner M, et al. (2010) Complications in auditory brainstem implant surgery in adults and children. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 31:558\u2013564. doi: 10.1097\/MAO.0b013e3181db7055","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"3257_CR48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1054\/bjoc.1999.1030","volume":"82","author":"ME Baser","year":"2000","unstructured":"Baser ME, Evans DG, Jackler RK, et al. (2000) Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br J Cancer 82:998. doi: 10.1054\/bjoc.1999.1030","journal-title":"Br J Cancer"},{"key":"3257_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/GIM.0b013e3181ac9a27","volume":"11","author":"DGR Evans","year":"2009","unstructured":"Evans DGR (2009) Neurofibromatosis 2 [bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. Genet Med Off J Am Coll Med Genet 11:599\u2013610. doi: 10.1097\/GIM.0b013e3181ac9a27","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"3257_CR50","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1227\/NEU.0b013e31820c0474","volume":"68","author":"CYH Choi","year":"2011","unstructured":"Choi CYH, Soltys SG, Gibbs IC, et al. (2011) Stereotactic radiosurgery of cranial nonvestibular schwannomas: results of single- and multisession radiosurgery. Neurosurgery 68:1200\u20131208 . doi: 10.1227\/NEU.0b013e31820c0474 discussion 1208","journal-title":"Neurosurgery"},{"key":"3257_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11060-015-1828-8","volume":"124","author":"A Hochart","year":"2015","unstructured":"Hochart A, Gaillard V, Baroncini M, et al. (2015) Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2. J Neuro-Oncol 124:229\u2013236. doi: 10.1007\/s11060-015-1828-8","journal-title":"J Neuro-Oncol"},{"key":"3257_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not242","author":"M Giovannini","year":"2014","unstructured":"Giovannini M, Bonne N-X, Vitte J, et al. (2014) mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro-Oncol. doi: 10.1093\/neuonc\/not242","journal-title":"Neuro-Oncol"},{"key":"3257_CR53","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/neuonc\/not150","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA, Legault G, Hagiwara M, et al. (2014) Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro-Oncol 16:292\u2013297. doi: 10.1093\/neuonc\/not150","journal-title":"Neuro-Oncol"},{"key":"3257_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-014-1710-0","volume":"122","author":"S Goutagny","year":"2015","unstructured":"Goutagny S, Raymond E, Esposito-Farese M, et al. (2015) Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas. J Neuro-Oncol 122:313\u2013320. doi: 10.1007\/s11060-014-1710-0","journal-title":"J Neuro-Oncol"},{"key":"3257_CR55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.spen.2015.10.008","volume":"22","author":"M Ruggieri","year":"2015","unstructured":"Ruggieri M, Pratic\u00f2 AD, Evans DG (2015) Diagnosis, management, and new therapeutic options in childhood Neurofibromatosis type 2 and related forms. Semin Pediatr Neurol 22:240\u2013258. doi: 10.1016\/j.spen.2015.10.008","journal-title":"Semin Pediatr Neurol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-016-3257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-016-3257-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-016-3257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T18:46:20Z","timestamp":1657392380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-016-3257-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3257"],"URL":"https:\/\/doi.org\/10.1007\/s00381-016-3257-1","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]}}}